Author

A. Bennaceur Griscelli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. Desterke· 3 shared A. Foudi· 2 shared A. G. Turhan· 2 shared A. TURHAN· 2 shared F. Griscelli· 2 shared O. Feraud· 2 shared P. Hugues· 2 shared G. Telliam· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

C. Desterke

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

miR-495-3p Sensitizes BCR::ABL1 Expressing Leukemic cells to Tyrosine Kinase Inhibitors by Targeting Multidrug Resistance 1 Gene including in T315I Mutated cells

Y. Rittavee, J. Artus, C. Desterke, I. Simanic, L. Eduardo Botelho de Souza, S. Riccaldi, S. Coignard, Y. Ijjeh, P. Hugues, A. Bennaceur Griscelli, A. G. Turhan, A. Foudi

This study shows miR-495-3p reduces CML cell growth and TKI resistance by targeting MDR1, especially in T315I-mutant cells, and identifies it as a potential therapeutic target.

Experimental Hematology · Feb 1, 2023Peer-reviewedCancer Biology

Evidence of Increased Hemangioblastic and Early Hematopoietic Potential in Chronic Myeloid Leukemia (CML)-derived Induced Pluripotent Stem Cells (iPSC)

G. Telliam, O. Feraud, S. Baykal, F. Griscelli, J. Imeri, T. Latsis, A. Bennaceur Griscelli, A. TURHAN

This study shows that CML-derived iPSC have expanded hemangioblast and hematopoietic progenitor potential compared to H1-ESC, with AHR signaling as a potential therapeutic target.

bioRxiv · Jun 17, 2020Cancer Biology

Evidence of massive leukemic progenitor expansion in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)

A. Turhan, P. Hugues, N. Sorel, C. Desterke, J. H. Bourhis, A. Bennaceur Griscelli, J. C. Chomel

The paper shows that leukemic progenitor expansion occurs in peripheral blood before cytological changes in CML patients after TKI discontinuation.

bioRxiv · Oct 22, 2019Cancer Biology

iPSC-derived Cancer Organoids Recapitulate Genomic and Phenotypic Alterations of c-met-mutated Hereditary Kidney Cancer

J. W. Hwang, C. Desterke, O. Feraud, S. Richard, S. Ferlicot, V. Verkarre, J. J. Patard, J. Loisel-Duwattez, A. Foudi, F. Griscelli, A. Bennaceur Griscelli, A. G. Turhan

The paper generates c-met-mutated iPSC-derived kidney organoids that recapitulate genomic and phenotypic features of PRCC, identifying common genes and validating their expression in both organoids and patient tumors.

bioRxiv · Jan 11, 2019 · PreprintCancer Biology